Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Serial interval and basic reproduction number of SARS-CoV-2 Omicron variant in South Korea

Dasom Kim, Jisoo Jo, Jun-Sik Lim, Sukhyun Ryu
doi: https://doi.org/10.1101/2021.12.25.21268301
Dasom Kim
1Department of Preventive Medicine, Konyang University College of Medicine, Daejeon, South Korea
2Onehealth Research Institute, Konyang University College of Medicine, Daejeon, South Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jisoo Jo
2Onehealth Research Institute, Konyang University College of Medicine, Daejeon, South Korea
3Department of Nursing, Konyang University, Daejeon, South Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun-Sik Lim
2Onehealth Research Institute, Konyang University College of Medicine, Daejeon, South Korea
4Ecole Nationale Vétérinaire de Toulouse, Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sukhyun Ryu
1Department of Preventive Medicine, Konyang University College of Medicine, Daejeon, South Korea
2Onehealth Research Institute, Konyang University College of Medicine, Daejeon, South Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gentryu@onehealth.or.kr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

South Korea is experiencing the community transmission of the SARS-CoV-2 Omicron variant (B.1.1.529). We estimated that the mean (± standard deviation) serial interval was 2.22 (± 1.62) days, and the basic reproduction number was 1.90 (95% Credible Interval, 1.50–2.43) for the Omicron variant outbreak in South Korea.

Main text

While the SARS-CoV-2 Delta variant is now dominant worldwide, the emergence of the SARS-CoV-2 Omicron variant (B.1.1.529) is causing global concern with its increasing spread.1 However, whether the Omicron variant has a faster transmission and/or greater transmissibility in comparison with the Delta variant remains unclear. In the present study, we estimated serial interval and basic reproduction number (R0), involved in the community transmission of the Omicron variant that was initiated from imported cases in South Korea.

We collected publicly available data of the case of the Omicron variant from the Korean public health authorities.2, 3 To identify the Omicron variant, public health authorities conducted whole-genome sequencing from respiratory samples from the epidemiologically linked individuals with the omicron variant who tested positive for SARS-CoV-2 by RT-PCR. The Omicron variant case included occurred during November 25, 2021 – December 16, 2021, when the community transmission that was initiated from imported cases reported from the Korea Disease Control and Prevention Agency. The data included contact tracing with other reported cases of the Omicron variant and demographic characteristics of the cases, including age, date of symptom onset, source of infection.

We computed the serial interval as the number of days between the infector and that of the infectee in the transmission pairs. Furthermore, we estimated the serial interval distribution by fitting a normal distribution.4

For the newly emerging infectious diseases, the number of cases increases exponentially in the initial phase of an outbreak. The observed value of the exponential growth rate (r) is often related to the basic reproductive number, R0. 4, 5

In this epidemic theory, R0 can be defined as Embedded Image where Tg is the mean generation interval, defined as the mean time interval between the infections of the infector and infectee in a transmission chain. Because the time of infection of the case is usually unobserved, we used the serial interval distribution acquiredfrom this study as a proxy of generation time distribution.4, 6

Of the total 131 cases, 56% of cases (n=74) were linked with the church and of these, 31% (n=23) of the cases received two doses of COVID-19 vaccination (Table 1 and Figure 1). We identified 18 transmission pairs having the date of symptom onset for both infector and infectee. The estimated mean serial interval was 2.22 days (95% Credible Interval [CrI], 1.48–2.97) and the standard deviation of the serial interval estimate was 1.62 days (95% CrI, 0.87–2.37) (Figure 2). The R0 in the outbreak was estimated to be 1.90 (95% CrI 1.50–2.43).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Demographic characteristics of 131 confirmed cases of the SARS-CoV-2 Omicron variant in South Korea.

Figure 1.
  • Download figure
  • Open in new tab
Figure 1.

Transmission chain (A) and epidemic curve (B) of laboratory-confirmed SARS-CoV-2 Omicron variant infection associated with the church (n=74) in South Korea.

Figure 2.
  • Download figure
  • Open in new tab
Figure 2.

Estimated serial interval distribution of the SARS-CoV-2 Omicron variant. The solid line indicates a fitted normal distribution

Compared with the previous finding of a Korean study on the Delta variant (mean serial interval as 3.3 days and R0 as 1.0),4 our findings suggest that the Omicron variant is highly transmissible and likely possesses faster spreading potential in the community. Therefore, quarantine, rapid contact tracing, isolation of asymptomatic contacts, strict adherence to public health measures, and COVID-19 vaccination (including booster doses) remain essential to reduce the community transmission of the Omicron variant.

The limitation of the study is that we estimated the serial interval based on symptomatic cases which may overestimate the result. Second, due to the limitation of the data, we have not analyzed the impact of COVID-19 vaccination against transmission. Third, in the early phase of this outbreak, 14-day isolation had been implemented for all individuals who had any risk of exposure to the case. Furthermore, 80% of the Korean population has received two doses of COVID-19 vaccination as of early December 2021. Therefore, our estimate of transmissibility would not be generalizable in resource-limited countries. Additional study in different settings is warranted to provide evidence for the efficient policy decision-making for the public health measures against the Omicron variant transmission.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Funding

This work was supported by the Basic Science Research Program through the National Research Foundation of Korea by the Ministry of Education (NRF-2020R1I1A3066471).

Conflict of interest

All authors declared no competing interest.

Ethical approval and consent to participate

This study did not require institutional review board approval or informed consent, because all data used were anonymous and publicly available on public health agency websites.

Acknowledgments

We appreciate the South Korean public health authorities’ response to COVID-19.

References

  1. ↵
    Karim SSA, Karim QA. Omicron Sars-Cov-2 Variant: A new chapter in the covid-19 pandemic. The Lancet. doi: 10.1016/S0140-6736(21)02758-6.
    OpenUrlCrossRefPubMed
  2. ↵
    Korea Centers for Disease Control and Prevention Agency. Press release. Available from: https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015 (17 December 2021, date last accessed).
  3. ↵
    Incheon Michuhol-Gu. Status of COVID-19 in Michuhol-gu, Incheon. Available from: https://www.michuhol.go.kr/main/covid_19.do (17 December 2021, date last accessed).
  4. ↵
    Hwang H, Lim JS, Song SA, et al. Transmission dynamics of the delta variant of sars-cov-2 infections in South Korea. J Infect Dis 2021. doi: 10.1093/infdis/jiab586.
    OpenUrlCrossRef
  5. ↵
    Wallinga J, Lipsitch M. How generation intervals shape the relationship between growth rates and reproductive numbers. Proc Biol Sci 2007; 274(1609):599–604.
    OpenUrlCrossRefPubMedWeb of Science
Back to top
PreviousNext
Posted December 25, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Serial interval and basic reproduction number of SARS-CoV-2 Omicron variant in South Korea
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Serial interval and basic reproduction number of SARS-CoV-2 Omicron variant in South Korea
Dasom Kim, Jisoo Jo, Jun-Sik Lim, Sukhyun Ryu
medRxiv 2021.12.25.21268301; doi: https://doi.org/10.1101/2021.12.25.21268301
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Serial interval and basic reproduction number of SARS-CoV-2 Omicron variant in South Korea
Dasom Kim, Jisoo Jo, Jun-Sik Lim, Sukhyun Ryu
medRxiv 2021.12.25.21268301; doi: https://doi.org/10.1101/2021.12.25.21268301

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (496)
  • Anesthesia (106)
  • Cardiovascular Medicine (1109)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (505)
  • Epidemiology (9795)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2327)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1567)
  • Health Policy (737)
  • Health Systems and Quality Improvement (608)
  • Hematology (238)
  • HIV/AIDS (508)
  • Infectious Diseases (except HIV/AIDS) (11665)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2152)
  • Nursing (134)
  • Nutrition (340)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (519)
  • Oncology (1184)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (221)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (699)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (268)
  • Psychiatry and Clinical Psychology (2195)
  • Public and Global Health (4680)
  • Radiology and Imaging (785)
  • Rehabilitation Medicine and Physical Therapy (458)
  • Respiratory Medicine (625)
  • Rheumatology (275)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (211)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)